Update on the Changing Epidemiology of Clostridium Difficile-associated Disease

Overview

Journal Nat Clin Pract Gastroenterol Hepatol

Specialty Gastroenterology

Date 2008 Jan 5

PMID 18174906

Citations 47

Authors

Lynne V McFarland

Affiliations

Soon will be listed here.

Abstract

In the past, Clostridium difficile-associated disease (CDAD) was thought of mainly as a nosocomial disease associated with the use of broad-spectrum antibiotics, but its epidemiology seems to be changing. Since 2002, outbreaks of severe CDAD associated with increased mortality and reduced effectiveness of treatment with metronidazole have focused attention on this challenging pathogen. A fluoroquinolone-resistant strain of C. difficile (BI/NAP1/027) has been predominantly associated with these outbreaks. Changes in the epidemiology of CDAD include the emergence of new at-risk populations and the increased incidence of the disease. Infection control programs and more effective treatments offer hope that future outbreaks of CDAD can be controlled.

Citing Articles

infection leading to fulminant colitis with toxic megacolon.

Rajack F, Medford S, Naab T Autops Case Rep. 2023; 13:e2023457.

PMID: 38034515 PMC: 10687841. DOI: 10.4322/acr.2023.457.

A study into the effect of Shirota in preventing antibiotic associated diarrhoea including infection in patients with spinal cord injuries: a multicentre randomised, double-blind, placebo-controlled trial.

Wong S, Hirani S, Forbes A, Kumar N, Hariharan R, ODriscoll J EClinicalMedicine. 2021; 40:101098.

PMID: 34541475 PMC: 8435694. DOI: 10.1016/j.eclinm.2021.101098.

Mathematically modeling the effect of touch frequency on the environmental transmission of Clostridioides difficile in healthcare settings.

Sulyok C, Fox L, Ritchie H, Lanzas C, Lenhart S, Day J Math Biosci. 2021; 340:108666.

PMID: 34310932 PMC: 9421614. DOI: 10.1016/j.mbs.2021.108666.

Development and validation of a simple and robust model to predict 30-day mortality in patients with -associated enterocolitis.

Katzer K, Hagel S, Reuken P, Bruns T, Stallmach A BMJ Open Gastroenterol. 2020; 7(1).

PMID: 32912845 PMC: 7484870. DOI: 10.1136/bmjgast-2020-000468.

Comparing the efficacy and safety of faecal microbiota transplantation with bezlotoxumab in reducing the risk of recurrent infections: a systematic review and Bayesian network meta-analysis of randomised controlled trials.

Alhifany A, Almutairi A, Almangour T, Shahbar A, Abraham I, Alessa M BMJ Open. 2019; 9(11):e031145.

PMID: 31699731 PMC: 6858162. DOI: 10.1136/bmjopen-2019-031145.